Citius Oncology, Inc. (CTOR NASDAQ) stock market data APIs
$1.8379
0.04(2.2%)
as of September 15, 2025
Try our APIs with
free plan!
Citius Oncology, Inc. Financial Data Overview
Price chart is built with
Anychart
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.
Prev. Close
1.8379
Open
1.8738
High
1.9485
Low
1.8296
52 wk Range
0.551-6.19
Market Cap
154 M
Shares Outstanding
83 513 K
EPS
-0.08
Beta
3.01
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Citius Oncology, Inc. data using free add-ons & libraries
Get Citius Oncology, Inc. Fundamental Data
Citius Oncology, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Citius Oncology, Inc. News
New
Citius Oncology Raises $9 Mln Through Direct Offering And Private Placement
(RTTNews) - Citius Oncology, Inc. (CTOR), a subsidiary of Citius Pharmaceuticals, Inc., has entered into a securities purchase agreement with an institutional investor for a registered direct offering...
Citius Oncology deploys AI platform to support LYMPHIR launch
NEW JERSEY - Citius Oncology, Inc. (NASDAQ:CTOR) has implemented an artificial intelligence platform to enhance its commercial operations ahead of the anticipated launch of LYMPHIR, a treatment for cu...
Citius Oncology Beats Fiscal Q3 EPS
Key Points GAAP loss per share of ($0.08) for Q3 FY2025 beat analyst expectations by $0.07 No revenue was reported for Q3 FY2025, as LYMPHIR has not yet launched commercially.These 10 stocks could mi...
Form 8K Citius Oncology Inc For: 12 August
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
